To investigate a possible role of Evi1 in the differential atRA responsiveness of LSCs from LSK- and CMP-derived AML, LCLSK_MLL-AF9 were transduced with shRNAs against Evi1 or with a control shRNA, and transplanted into congenic recipient mice. This evidence concerns the gene MECOM and acute myeloid leukemia.